Akari Interest Income from 2010 to 2026

AKTX Stock

USD 0.25 0.01 4.17%

Akari Therapeutics Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income will likely drop to 6,840 in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

0.0

Current Value

1000

Quarterly Volatility

509.7 K

Covid

Interest Hikes

Check Akari Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akari Therapeutics' main balance sheet or income statement drivers, such as Selling General Administrative of 7.8 M, Other Operating Expenses of 17.4 M or Research Development of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.0E-4. Akari financial statements analysis is a perfect complement when working with Akari Therapeutics Valuation or Volatility modules.

Build AI portfolio with Akari Stock

Check out the analysis of Akari Therapeutics Correlation against competitors.

The evolution of Interest Income for Akari Therapeutics PLC provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Akari Therapeutics compares to historical norms and industry peers.

Latest Akari Therapeutics' Interest Income Growth Pattern

Below is the plot of the Interest Income of Akari Therapeutics PLC over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Akari Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akari Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Akari Interest Income Regression Statistics

	Arithmetic Mean	2,966,293
	Geometric Mean	205,840
	Coefficient Of Variation	136.50
	Mean Deviation	3,753,958
	Median	143,195
	Standard Deviation	4,049,047
	Sample Variance	16.4T
	Range	8.3M
	R-Value	(0.83)
	Mean Square Error	5.3T
	R-Squared	0.70
	Significance	0.000031
	Slope	(669,205)
	Total Sum of Squares	262.3T

Akari Interest Income History

	2026	6840.0
	2025	7200.0
	2024	8000.0
	2023	82 K
	2022	45.9 K
	2021	10.6 K
	2020	13.6 K

Other Fundumenentals of Akari Therapeutics PLC

Net Interest Income

Akari Therapeutics Interest Income component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Net Debt	Short Term Debt	Current Deferred Revenue	Short Long Term Debt	Intangible Assets	Net Tangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Surpluse	Capital Stock
Total Assets		0.94	-0.36	0.76	0.05	0.89	0.53	0.35	-0.48	0.61	-0.48	0.63	0.67	0.62	0.47	0.59	-0.46	0.5	-0.17
Total Stockholder Equity	0.94		-0.16	0.52	0.22	0.69	0.76	0.47	-0.7	0.53	-0.49	0.56	0.4	0.8	0.67	0.47	-0.19	0.25	0.02
Retained Earnings	-0.36	-0.16		-0.57	-0.02	-0.56	0.16	0.0	-0.2	-0.79	0.68	-0.81	-0.55	0.14	0.12	0.1	0.85	-0.64	0.82
Accounts Payable	0.76	0.52	-0.57		-0.27	0.94	-0.14	-0.01	0.18	0.49	-0.26	0.51	0.98	0.01	-0.1	0.71	-0.8	0.81	-0.43
Net Receivables	0.05	0.22	-0.02	-0.27		-0.19	0.4	0.67	-0.29	0.39	-0.41	0.39	-0.3	0.26	0.73	-0.32	0.16	-0.26	0.25
Total Liab	0.89	0.69	-0.56	0.94	-0.19		0.13	0.12	-0.09	0.59	-0.37	0.61	0.9	0.25	0.11	0.64	-0.73	0.74	-0.39
Total Current Assets	0.53	0.76	0.16	-0.14	0.4	0.13		0.52	-0.98	0.32	-0.39	0.33	-0.28	0.96	0.82	-0.05	0.35	-0.29	0.25
Common Stock	0.35	0.47	0.0	-0.01	0.67	0.12	0.52		-0.42	0.46	-0.44	0.47	-0.06	0.35	0.63	-0.19	-0.07	-0.08	0.51
Net Debt	-0.48	-0.7	-0.2	0.18	-0.29	-0.09	-0.98	-0.42		-0.25	0.33	-0.26	0.32	-0.95	-0.76	0.04	-0.42	0.32	-0.23
Short Term Debt	0.61	0.53	-0.79	0.49	0.39	0.59	0.32	0.46	-0.25		-0.76	0.99	0.4	0.31	0.38	-0.1	-0.63	0.5	-0.49
Current Deferred Revenue	-0.48	-0.49	0.68	-0.26	-0.41	-0.37	-0.39	-0.44	0.33	-0.76		-0.78	-0.2	-0.31	-0.39	0.22	0.45	-0.28	0.39
Short Long Term Debt	0.63	0.56	-0.81	0.51	0.39	0.61	0.33	0.47	-0.26	0.99	-0.78		0.42	0.31	0.38	-0.09	-0.64	0.52	-0.5
Intangible Assets	0.67	0.4	-0.55	0.98	-0.3	0.9	-0.28	-0.06	0.32	0.4	-0.2	0.42		-0.14	-0.19	0.7	-0.83	0.82	-0.41
Net Tangible Assets	0.62	0.8	0.14	0.01	0.26	0.25	0.96	0.35	-0.95	0.31	-0.31	0.31	-0.14		0.79	0.15	0.31	-0.2	0.15
Property Plant Equipment	0.47	0.67	0.12	-0.1	0.73	0.11	0.82	0.63	-0.76	0.38	-0.39	0.38	-0.19	0.79		0.05	0.31	-0.26	0.3
Net Invested Capital	0.59	0.47	0.1	0.71	-0.32	0.64	-0.05	-0.19	0.04	-0.1	0.22	-0.09	0.7	0.15	0.05		-0.19	0.4	0.01
Net Working Capital	-0.46	-0.19	0.85	-0.8	0.16	-0.73	0.35	-0.07	-0.42	-0.63	0.45	-0.64	-0.83	0.31	0.31	-0.19		-0.78	0.57
Capital Surpluse	0.5	0.25	-0.64	0.81	-0.26	0.74	-0.29	-0.08	0.32	0.5	-0.28	0.52	0.82	-0.2	-0.26	0.4	-0.78		-0.54
Capital Stock	-0.17	0.02	0.82	-0.43	0.25	-0.39	0.25	0.51	-0.23	-0.49	0.39	-0.5	-0.41	0.15	0.3	0.01	0.57	-0.54

Click cells to compare fundamentals

About Akari Therapeutics Financial Statements

Akari Therapeutics investors use historical fundamental indicators, such as Akari Therapeutics' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Akari Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	7.2 K	6.8 K
Net Interest Income	-212.4 K	-201.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Akari Stock Analysis

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Akari Interest Income from 2010 to 2026

Latest Akari Therapeutics' Interest Income Growth Pattern

Akari Interest Income Regression Statistics

Akari Interest Income History

Other Fundumenentals of Akari Therapeutics PLC

Akari Therapeutics Interest Income component correlations

About Akari Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Akari Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY